HYFT
ImmunoPrecise Antibodies Ltd.
1.50$
-3.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -354.0% | – | – | – | – | – | – | – | – | – | |
| – | +3,927.0% | +20.8% | +805.1% | +394.1% | +50.6% | +8.9% | +1.5% | +77.4% | -14.2% | -10.7% | -69.1% | |
| – | – | – | +516.8% | -8.8% | -33.7% | +271.8% | +12.2% | -37.0% | -21.0% | -71.0% | +186.5% | |
| – | +107,114.9% | +430.0% | -150.8% | – | -292.6% | – | – | -662.9% | – | -88.5% | -831.6% | |
| – | -14.0% | +2,936.3% | -34.9% | +86.7% | -10.8% | +147.9% | -11.9% | +18.9% | -6.6% | -42.8% | -51.0% | |
| – | +13,498.0% | +114.0% | +4,007.5% | -69.3% | -28.1% | +55.1% | +112.1% | -62.2% | -20.5% | -48.9% | – | |
| – | -67.5% | +38.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +39.0% | +0.1% | – | -129.3% | |
| – | +15,217.8% | – | +209.5% | -4.6% | -98.1% | +24,730.4% | -93.4% | -121.5% | – | +1,358.7% | -99.2% | |
| – | – | +1,653.1% | -134.5% | – | -176.3% | – | -130.1% | – | – | – | -88.4% | |
| – | – | -569.8% | – | – | – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.